SCHEMBL30046979

SCHEMBL30046979

Oc1c(F)c(-c2ccc(OC(F)(F)F)cc2)c(O)c(F)c1-c1ccc(OC(F)(F)F)cc1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ AKR1C2 P52895 1/20 0.44
▸ AKR1C1 Q04828 1/20 0.44
▸ AURKA O14965 1/20 0.44
▸ TPX2 Q9ULW0 1/20 0.44
▸ MAPT P10636 1/20 0.42
▸ EPHX2 P34913 1/20 0.42
▸ SCN5A Q14524 8/20 0.41
▸ KIF11 P52732 1/20 0.40
▸ NISCH Q9Y2I1 1/20 0.40
▸ SCN1A P35498 1/20 0.40
▸ SCN2A Q99250 1/20 0.40
▸ MAOB P27338 1/20 0.39
▸ AOC3 Q16853 1/20 0.39
▸ AR P10275 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ NOTUM Q6P988 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30366911 0.77 KIF11 (0.40) AURKATPX2MAPTEPHX2SCN5A
SCHEMBL29019406 0.76 AKR1C2 (0.45) AKR1C2AKR1C1AURKATPX2MAPT
SCHEMBL28716842 0.76 MAOB (0.41) AURKATPX2MAPTEPHX2SCN5A
SCHEMBL508237 0.75 AURKA (0.57) AKR1C2AKR1C1AURKATPX2MAPT
SCHEMBL23041015 0.74 KIF11 (0.41) AKR1C2AKR1C1AURKATPX2SCN5A
SCHEMBL30046652 0.74 KIF11 (0.41) SCN5AKIF11NISCHSCN1ASCN2A
SCHEMBL254957 0.73 MAPT (0.56) MAPTEPHX2KIF11NISCHMAOB
SCHEMBL7938385 0.73 KIF11 (0.50) AURKATPX2MAPTEPHX2SCN5A
SCHEMBL221511 0.72 MAPT (0.52) AURKATPX2MAPTEPHX2MAOB
SCHEMBL20768218 0.72 AURKA (0.54) AKR1C2AKR1C1AURKATPX2EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11492360-B2 Organic compound and electroluminescent device containing the same Beijing Summer Sprout Technology Co., Ltd. (CN) 2022-11-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11492360-B2 Organic compound and electroluminescent device containing the same OCIAD1, OCIAD2, SLCO4C1 AKR1C2 3387/4885AKR1C1 3279/4885AURKA 1699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback